Examination for the effect of combination therapy with Eldecalcitol and Alendronate in primary osteoporotic patients
Phase 4
- Conditions
- Osteoporosis
- Registration Number
- JPRN-UMIN000008191
- Lead Sponsor
- Showa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who are diagnosed as contraindication of Alendronate treatments 2. Patients who are diagnosed as contraindication of Eldecalcitol treatments 3.Patients who have taken osteoporosis treatments other than Alendronate 4.Patients with cancer 5. Patients who are inappropriate for this study by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of lumbar spine bone mineral density
- Secondary Outcome Measures
Name Time Method